The Vice President, Clinical Strategy & Product owns LucyRx''s clinical and non-clinical product portfolio end to end - defining what gets built, why it wins in market, and how clinical evidence, formulary strategy, and client-facing clinical engagement come together in a sellable offering. Set the bar for how work reaches market: discovery rigor, business case quality, launch readiness, and the evidence behind every claim the team makes, with formulary and benefit design decisions made alongside product decisions rather than after them.